Cargando…
Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is one of the most common digestive system tumors worldwide. Hypoxia and immunity are closely related in CRC; however, the role of hypoxia-immune–related lncRNAs in CRC prognosis is unknown. METHODS: Data used in the current study were sourced from the Gene Expres...
Autores principales: | Luan, Likun, Dai, Youguo, Shen, Tao, Yang, Changlong, Chen, Zhenpu, Liu, Shan, Jia, Junyi, Li, Zhenhui, Fang, Shaojun, Qiu, Hengqiong, Cheng, Xianshuo, Yang, Zhibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516397/ https://www.ncbi.nlm.nih.gov/pubmed/36189298 http://dx.doi.org/10.3389/fimmu.2022.951455 |
Ejemplares similares
-
Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022) -
Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021) -
Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023) -
An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020) -
Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)